Abstract
At present, the treatment of choice for juvenile angiofibroma (JA) is surgery, which has evolved to endoscopic approaches, performed at referral centers.
The epicenter of JA is located in the sphenopalatine foramen, and its patterns of extension are medial and lateral, complicated due to the deep location of the structures involved and close proximity to critical vascular and neural elements.
These facts frequently predispose to incomplete tumor resection and disease recurrence, especially in advanced stages and extensive lateral invasion patterns (INCan stage IIB and more advanced). The majority of series report a mean recurrence rate of 35 %, mostly in advanced stages.
Several prognostic factors have been described that predispose to recurrence, in addition to advanced stages and extensive lateral dissemination in the central skull base. These additional factors include blood loss, tumor size, surgical margins, the expertise of the surgical team – the latter closely related with a rational application of endoscopic approaches for resection – and nonsurgical treatment.
Consequently, a rational design of the treatment strategy should be performed from the first surgical attempt, based on surgical expertise, comprising the use of endoscopy in medial and minor lateral extensions, and the utilization of open surgical approaches such as osteoplastic maxillotomy (medial and anterolateral), according to the major invasion of tumors. In very advanced cases, a maxillotomy or neuro-otological procedure (Fisch C), combined with an anterolateral and/or transtemporal neurosurgical approach, should be carried out. Radiotherapy is used for multiple recurrences and in major medial encasement of the cavernous sinus and carotid artery (INCan stage IVb).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lund VJ, Stammberger H, Nicolai P, et al. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl. 2010;22:1–143.
Nicolai P, Schreiber A, Bolzoni Villaret A. Juvenile angiofibroma: evolution of management. Int J Pediatr. 2012;2012:412545.
Huang Y, Liu Z, Wang J, Sun X, Yang L, Wang D. Surgical management of juvenile nasopharyngeal angiofibroma: analysis of 162 cases from 1995 to 2012. Laryngoscope. 2014;124:1942–6.
Carrillo JF, Albores O, Ramírez-Ortega MC, Aiello-Crocifoglio V, Oñate-Ocaña LF. An audit of nasopharyngeal fibromas. Eur J Surg Oncol. 2007;33:655–61.
Boghani Z, Husain Q, Kanumuri VV, Khan MN, Sangvhi S, Liu JK, Eloy JA. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope. 2013;123:859–69.
Alshaikh NA, Eleftheriadou A. Juvenile nasopharyngeal angiofibroma staging: an overview. Ear Nose Throat J. 2015;94:E12–22.
Carrillo JF, Maldonado F, Albores O, Ramírez-Ortega MC, Oñate-Ocaña LF. Juvenile nasopharyngeal angiofibroma: clinical factors associated with recurrence, and proposal of a staging system. J Surg Oncol. 2008;98:75–80.
Marshall AH, Bradley PJ. Management dilemmas in the treatment and follow-up of advanced juvenile nasopharyngeal angiofibroma. ORL J Otorhinolaryngol Relat Spec. 2006;68:273–8.
Önerci TM, Yücel ÖT, Ögretmenoglu O. Endoscopic surgery in treatment of juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2003;67:1219–25.
Snyderman CH, Pant H, Carrau RL, Gardner P. A new endoscopic staging system for angiofibromas. Arch Otolaryngol Head Neck Surg. 2010;136:588–94.
Ochoa-Carrillo FJ, Carrillo JF, Frías M. Staging and treatment of nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol. 1997;254:200–4.
Onerci M, Oğretmenoğlu O, Yücel T. Juvenile nasopharyngeal angiofibroma: a revised staging system. Rhinology. 2006;44:39–45.
Leong SC. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope. 2013;123:1125–31.
Lutz J, Holtmannspötter M, Flatz W, Meier-Bender A, Berghaus A, Brückmann H, Zengel P. Preoperative embolization to improve the surgical management and outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a single center: 10-year experience. Clin Neuroradiol. 2015;29:1–9.
Nicolai P, Villaret AB, Farina D, Nadeau S, Yakirevitch A, Berlucchi M, Galtelli C. Endoscopic surgery for juvenile angiofibroma: a critical review of indications after 46 cases. Am J Rhinol Allergy. 2010;24:e67–72.
Carrillo JF, Celis MA, Ramírez-Ortega M, Rivas B, Ochoa FJ. Osteoplastic maxillotomy for treatment of neoplasms of the nasopharynx and infratemporal fossa. Ann Otol Rhinol Laryngol. 2005;114(1 Pt 1):58–64.
Chandler JR, Goulding R, Moskowitz L, Quencer RM. Nasopharyngeal angiofibromas: staging and management. Ann Otol Rhinol Laryngol. 1984;93:322–9.
Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT. Angiofibroma. Changes in staging and treatment. Arch Otolaryngol Head Neck Surg. 1996;122:122–9.
Sun XC, Wang DH, Yu HP, Wang F, Wang W, Jiang JJ. Analysis of risk factors associated with recurrence of nasopharyngeal angiofibroma. J Otolaryngol Head Neck Surg. 2010;39:56–61.
Ye D, Shen Z, Wang G, Deng H, Qiu S, Zhang. Analysis of factors in successful nasal endoscopic resection of nasopharyngeal angiofibroma. Acta Otolaryngol. 2016;136:205–13.
Andrews JC, Fisch U, Valavanis A, Aeppli U, Makek MS. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope. 1989;99:429–37.
Herman P, Lot G, Chapot R, Salvan D, Huy PT. Long-term follow-up of juvenile nasopharyngeal angiofibromas: analysis of recurrences. Laryngoscope. 1999;109:140–7.
Kasper ME, Parsons JT, Mancuso AA, et al. Radiation therapy for juvenile angiofibroma: evaluation by CT and MRI, analysis of tumor regression and selection of patients. Int J Radiat Oncol Biol Phys. 1993;25:689–94.
Sun XC, Li H, Liu ZF, Hu L, Yu HP, Wang JJ, Liu Q, Liu J, Wang DH. Endoscopic assisted sublabial and buccolabial incision approach for juvenile nasopharyngeal angiofibroma with extensive infratemporal fossa extension. Int J Pediatr Otorhinolaryngol. 2012;76:1501–6.
Catalano PJ, Biller HF. Extended osteoplastic maxillotomy. A versatile new procedure for wide access to the central skull base and infratemporal fossa. Arch Otolaryngol Head Neck Surg. 1993;119:394–400.
Fisch U. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope. 1983;93:36–44.
Fagan JJ, Snyderman CH, Carrau RL, Janecka IP. Nasopharyngeal angiofibromas: selecting a surgical approach. Head Neck. 1997;19:391–9.
Tyagi I, Syal R, Goyal A. Recurrent and residual juvenile angiofibromas. J Laryngol Otol. 2007;121:460–7.
Reddy KA, Mendenhall WM, Amdur RJ, Stringer SP, Cassisi NJ. Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol. 2001;22:172–5.
Mallick S, Benson R, Bhasker S, Mohanti BK. Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy. Acta Otorhinolaryngol Ital. 2015;35:75–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Carrillo, J.F., Carrillo, L.C., Ramirez-Ortega, M. (2017). Recurrence of Juvenile Angiofibroma and its Prevention. In: Dubey, S., Schick, B. (eds) Juvenile Angiofibroma. Springer, Cham. https://doi.org/10.1007/978-3-319-45343-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-45343-9_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45341-5
Online ISBN: 978-3-319-45343-9
eBook Packages: MedicineMedicine (R0)